[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368987-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368987-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-nek6-as-a-potential-biomarker-for-prognosis-in-glioma-and-its-functional-implications","Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications","","Purpose: Investigate Never in mitosis gene A-related kinase 6 (NEK6) as a prognostic biomarker and explore its functional roles in glioma and other cancers. Methods: Conduct pan-cancer analyses of NEK6 expression, immune characteristics, and clinical prognosis, then validate key conclusions using multiple cell experiments and clinical-sample-based analyses. Results: NEK6 is upregulated in gliomas and correlates with poor outcomes; single-cell data link NEK6 to malignant cells and Mono/Macrophages. Reduced NEK6 suppresses glioma growth and migration by halting G2/M and inducing apoptosis. Conclusion: NEK6 shows prognostic value and therapeutic potential in glioma.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-nek6-as-a-potential-biomarker-for-prognosis-in-glioma-and-its-functional-implications/368987/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-nek6-as-a-potential-biomarker-for-prognosis-in-glioma-and-its-functional-implications/368987.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the study on NEK6 in glioma?","Question",{"text":63,"@type":64},"To evaluate the prognostic value of NEK6 and investigate its potential functions, with a focus on gliomas and related cancer contexts.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was NEK6 analyzed and validated in the research?",{"text":68,"@type":64},"NEK6 was assessed using pan-cancer expression and immune/prognosis analyses, and results were validated with cell experiments (e.g., clone formation, MTT, flow cytometry) and clinical-sample analyses such as immunohistochemistry.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings link NEK6 to glioma prognosis and tumor behavior?",{"text":72,"@type":64},"NEK6 is significantly upregulated in gliomas, higher NEK6 levels associate with poor clinical prognosis, and NEK6 reduction limits growth and migration by causing G2/M phase arrest and triggering apoptosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368987,1791125379,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of Neuro-Oncology (2026) 176:113  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1060-025-05260-1  \nRESEARCH  \nIdentification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications  \nDanwen Wang1 · Zisong Wang2,3 · Jian Xu2 · Yuxiang Cai2 · Xiaoping Liu2 · Zhiqiang Li4  \nReceived: 6 August 2025 / Accepted: 23 September 2025 / Published online: 10 December 2025 © The Author(s) 2025  \nAbstract  \nPurpose Never in mitosis gene A-related kinase 6 (NEK6) is involved in mitotic cell cycle. The objective of the present study is to comprehensively explore the prognostic value of NEK6 and its potential functions in multiple cancers, especially in gliomas.  \nMethods We performed comprehensive analyses of NEK6 in pan-cancer, including expression profile, immune characteristics and its relationship with clinical prognosis. Moreover, we validated our significant conclusions through multiple cell experiments (such as clone formation assay, MTT assay and flow cytometry) and analyses based on clinical samples (such as immunohistochemistry analysis) .  \nResults NEK6 was significantly upregulated in gliomas. And our study indicated that the increased level of NEK6 was associated with poor clinical prognoses of patients. The single-cell analysis revealed that NEK6 overexpression was highly related to malignant cells and Mono/Macrophages (denoted as the monocyte and macrophage population) in glioma tissue. The decrease in NEK6 hindered the growth and migration capacity of the glioma cells, leading to a halt in the G2/M phase of the cell cycle and triggering apoptosis.  \nConclusion Taken together, our data uncovered the prognostic value, therapeutic potential, and molecular insight of NEK6 in glioma.  \nKeywords NEK6 · Glioma · Cancer biomarker · Tumor microenvironment · Cell cycle  \nDanwen Wang and Zisong Wang contributed equally to this work.  \n􀀍 Yuxiang Cai[grzzlbl@sina.com](grzzlbl@sina.com)  \n􀀍 Xiaoping Liu [liuxiaoping@whu.edu.cn](liuxiaoping@whu.edu.cn)  \n􀀍 Zhiqiang Li[lizhiqiang@whu.edu.cn](lizhiqiang@whu.edu.cn)  \n1 Department of Radiology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China  \n2 Department of Pathology, Zhongnan Hospital, Wuhan University, Wuhan 430071, China  \n3 School of Basic Medical Sciences, Wuhan University, Wuhan 430071, China  \n4 Department of Neurosurgery, Zhongnan Hospital, Wuhan University, Wuhan 430071, China  \nIntroduction  \nAs the main cause of death worldwide, cancer has become the most alarming disease that seriously affects public health with increasing incidence rate and mortality. The updated data of global cancer statistics in 2020 indicates that there were approximately 19.3 million new cancer cases, resulting in the deaths of nearly 10 million people worldwide [1] . At present, research on early tumor diagnosis and clinical treatment becomes increasingly crucial. Although significant advancements in cancer therapy strategies including radiotherapy, chemotherapy, surgery and molecular targeted therapeutic drugs, the side effects of medications and drug insensitivity have resulted in poor prognosis for cancer patients [2, 3] . Remarkably, identifying useful diagnostic biomarkers and therapeutic targets is currently urgent problems to resolve. Recently, an increasing number of researches revealed the general characteristics and heterogeneity of tumor pathogenesis by pan-cancer analysis, which could be beneficial in identifying pivotal  \nbiomarkers and understanding the relevant molecular functions in tumor biological processes [4–6] . Glioma, the most common primary intracranial malignant tumor, accounts for almost 80% of malignancies in the central nervous system (CNS) [7] . Although our previous research and numerous other attempts to develop effective prognostic markers and stratifications for glioma, glioma remains a type of malignant tumor with extremely poor prognosis due to genetic heterogeneity [8–10] . Therefore, it remains needful and urg","cbCais0pws6Wsb1l","https://ap.wps.com/l/cbCais0pws6Wsb1l","pdf",11165642,16,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main purpose of the study on NEK6 in glioma?\",\"answer\":\"To evaluate the prognostic value of NEK6 and investigate its potential functions, with a focus on gliomas and related cancer contexts.\"},{\"question\":\"How was NEK6 analyzed and validated in the research?\",\"answer\":\"NEK6 was assessed using pan-cancer expression and immune/prognosis analyses, and results were validated with cell experiments (e.g., clone formation, MTT, flow cytometry) and clinical-sample analyses such as immunohistochemistry.\"},{\"question\":\"What key findings link NEK6 to glioma prognosis and tumor behavior?\",\"answer\":\"NEK6 is significantly upregulated in gliomas, higher NEK6 levels associate with poor clinical prognosis, and NEK6 reduction limits growth and migration by causing G2/M phase arrest and triggering apoptosis.\"}]","Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications | PDF",1790180036,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2985743eb30a6d4c7de7737e9e371044.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b475145b9be06888058804a9e1083399.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d045bcc736bb6d16d1c5e8d8e00df97.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a5d2a4e4e3b4cf123e89a37632f0a92.webp",980,1301]